First Real-World Observational Study of the JADA System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG's Obstetrics & Gynecology

14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), ...

Related Keywords

Jersey City ,New Jersey ,United States ,New York ,Maryland ,Dena Goffman ,Thromb Haemost ,Patricia Carney ,Carvalho Pacagnella ,Centers For Disease ,Instagram ,Columbia University Irving Medical Center ,Organon Medical Affairs ,Safe Motherhood Initiative ,Womens Health ,Facebook ,Department Of Obstetrics ,World Health Organisation ,Agency For Healthcare Research ,Organon Company Stock ,Exchange Commission ,Twitter ,Glob Health ,Society For Maternal ,Linkedin ,Treating Abnormal Postpartum Uterine Bleeding ,Postpartum Hemorrhage ,Maternal Fetal Medicine ,Annual Pregnancy Meeting ,Post Hoc Analysis Supports Appropriate Control ,Loss Thresholds Prior ,Cumulative Blood Loss Prior ,Securities Litigation Reform ,Annual Report ,Ejada System ,Prev Med ,Maternal Morbidity ,Updated July ,Care Consensus ,Obstetric Hemorrhage ,Accessed April ,Van Hook ,Updated February ,Market Registry ,Disease Control ,Healthcare Research ,Company Stock ,Organon Company Chart ,Rganon Company Kurs ,Rganon Company Aktie ,